Author | Katherine Hasal


Improved Outcomes in Patients with Chronic Hepatitis C Treated with Sofosbuvir Velpatasvir

May 27, 2016

Treatment with fixed-dos combination sofosbuvir/velpatasvir yielded significant improvements in patient-reported outcomes.

Patients with Crohn's Disease Treated with Filgotinib Experienced Higher Rates of Clinical Remission and Improved Quality of Life Compared to Patients Who Received Placebo

May 27, 2016

Filgotinib is the first oral, JAK1-selective inhibitor showing efficacy in moderate-to-severe Crohn's disease patients.

Selective Blockade of IL-23 with Risankizumab Shows Promise as Therapy for Crohn's Disease

May 27, 2016

Risankizumab is a humanized monoclonal antibody that selectively inhibits IL-23 through specific targeting of the IL-23 p19 subunit.

Real-World Treatment Results with Ledipasvir-Sofosbuvir in Patients Coinfected with HIV and Hepatitis C

May 25, 2016

Researchers reported that SVR12 rates in real-world, post-transplant genotype 1 HCV patients treated with ledipasvir-sofosbuvir, with or without ribavirin, is 98% across regimens and various characteristics.